Limitation of collagen cross-Linking with hypoosmolar riboflavin solution: Failure in an extremely thin cornea

Cornea

Volumn 30, Issue 8, 2011, Pages 917-919

  Hafezi, Farhad ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

collagen cross linking; cornea; corneal; CXL; hypoosmolar; riboflavin

Indexed keywords

COLLAGEN; HYPOOSMOLAR RIBOFLAVIN; RIBOFLAVIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CORNEA DISEASE; CORNEA EDEMA; CORNEA SURGERY; CORNEA THICKNESS; CORNEAL COLLAGEN CROSS LINKING; CROSS LINKING; HUMAN; KERATOCONUS; MALE; OSMOLARITY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THIN CORNEA; TREATMENT FAILURE;

COLLAGEN; CORNEAL STROMA; CORNEAL TOPOGRAPHY; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; HUMANS; HYPOTONIC SOLUTIONS; KERATOCONUS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TREATMENT FAILURE; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 79960699306     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31820143d1     Document Type: Article

References (14)

1. Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg. 1999;15:711-713.
2. Coskunseven E, Jankov MR III, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refract Surg. 2009;25:371-376.
3. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135:620-627. (Pubitemid 36457967)
4. Hafezi F, Mrochen M, Kanellopoulos J, et al. Corneal collagen crosslinking with riboflavin/UVA for the treatment of induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035-2040. (Pubitemid 350167516)
5. Iseli HP, Thiel MA, Hafezi F, et al. Ultraviolet A/riboflavin corneal crosslinking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590-594.
6. Hafezi F, Dejica P, Majo F. Modified corneal collagen crosslinking (CXL) reduces corneal oedema and diurnal visual fluctuations in Fuchs' Dystrophy. Br J Ophthalmol. 2010; DOI bjo.2010.184978 [pii]10.1136/bjo.2010.184978
7. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin crosslinking of the cornea. Cornea. 2007;26:385-389.
8. Hafezi F, Mrochen M, Iseli HP, et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg. 2009;35:621-624.
9. Swartz T, Marten L, Wang M. Measuring the cornea: the latest developments in corneal topography. Curr Opin Ophthalmol. 2007;18: 325-333. (Pubitemid 46955300)
10. Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006;25:1057-1059. (Pubitemid 44885269)
11. Dohlman CH, Hedbys BO, Mishima S. The swelling pressure of the corneal stroma. Invest Ophthalmol. 1962;1:158-162.
12. Maurice DM, Giardini AA. Swelling of the cornea in vivo after the destruction of its limiting layers. Br J Ophthalmol. 1951;35:791-797.
13. Dohlman CL. Physiology of the Cornea: Corneal Edema. In: Smolin G, Thoft RA, eds. The Cornea: Scientific Foundations and Clinical Practice. Boston, Toronto: Little, Brown and Company; 1987:3-16.
14. Hara T, Maurice DM. Changes in the swelling pressure of the corneal stroma with time, hydration and temperature, determined by a new method. Exp Eye Res. 1972;14:40-48.